Clinical Reviews in Emergency Medicine| Volume 58, ISSUE 4, P610-615, April 2020

An Update and Review of Measles for Emergency Physicians



      It is vital for frontline emergency physicians to immediately recognize the signs and symptoms of measles to initiate appropriate therapy and prevent spread to the health care team and other patients.


      This review serves as a clinically practical updated reference for when the differential diagnosis includes measles.


      Measles is a highly contagious illness that classically presents with a rash, fever, cough, coryza, and conjunctivitis. Cases in the United States since 2000 have been attributed mainly to travelers who are infected abroad and then spread the illness to small, susceptible populations within the United States. Complications from measles are relatively common and can be associated with significant morbidity and mortality. Clinical suspicion should be confirmed with laboratory testing, which is most commonly a serum immunoglobulin M. The management of measles is mainly supportive. Patients that require more aggressive management include those who are pregnant, immunocompromised, or unvaccinated. Treatment may consist of the measles vaccine, intravenous immunoglobulin, vitamin A, and even ribavirin. Additionally, special precautions are required by hospital workers to help prevent the spread of the virus, which include N-95 masks and patient isolation in an airborne infection isolation room.


      Emergency physicians must be readily able to identify, contain patients with suspected measles, and determine who will need further medical management for this potentially life-threatening illness. As this public health crisis evolves, novel ways of screening for and reporting cases of measles is needed.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Centers for Disease Control and Prevention (CDC)
        Measles cases and outbreaks.
        (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        With end of New York outbreak, United States keeps measles elimination status.
        2019 (Available at:)
        • Moss W.
        Lancet. 2017; 390: 2490-2502
        • Strebel P.M.
        • Papania M.J.
        • Fiebelkorn A.P.
        • Halsey N.A.
        Measles vaccine.
        in: Plotkin S.A. Orenstein W.A. Offit P.A. Vaccines. 6th edn. Elsevier, Philadelphia, PA2012: 352-387
        • Weida J.A.
        Measles (Rubeola).
        in: Kellerman R.D. Rakel D. Conn's current therapy 2019. Elsevier, Philadelphia, PA2019: 580-582
        • Centers for Disease Control and Prevention (CDC)
        Interim measles infection prevention recommendations in healthcare settings.
        2019 (Available at:)
        • World Health Organization (WHO)
        (Available at:)
        Date accessed: January 31, 2020
        • Centers for Disease Control and Prevention (CDC)
        Measles. (February 5, 2018).
        (Available at:)
        Date accessed: January 31, 2020
        • Centers for Disease Control and Prevention (CDC)
        Vaccination coverage for selected diseases among children aged 19–35 months, by race, Hispanic origin, poverty level, and location of residence in metropolitan statistical area: United States, selected years 1998–2016.
        2017 (Available at:)
        Date accessed: January 31, 2020
        • Richards C.
        Principles of epidemiology, Lesson 1, Section 11.
        2012 (Available at:)
        • Gastañaduy P.A.
        • Budd J.
        • Fisher N.
        • et al.
        A measles outbreak in an underimmunized Amish community in Ohio.
        N Engl J Med. 2016; 375: 1343-1354
        • Dorrheim D.N.
        Measles elimination – using outbreaks to identify and close immunity gaps.
        N Engl J Med. 2016; 375: 1392-1393
        • Sandstrom A.
        Amid measles outbreak, New York closes religious exemption for vaccinations – but most states retain it.
        (Available at:)
        • Perry R.
        • Halsey N.
        The clinical significance of measles: a review.
        J Infect Dis. 2004; 189: S4-S16
        • Centers for Disease Control and Prevention (CDC)
        Koplik spots.
        (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        Measles rash.
        1966 (Available at:)
        • Partin B.G.
        • Centers for Disease Control and Prevention (CDC)
        Measles rash.
        1976 (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        Measles rash.
        1978 (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        Measles rash.
        1963 (Available at:)
        • Maldonado Y.A.
        • Shetty A.K.
        Rubeola virus: measles and subacute sclerosing panencephalitis.
        in: Long S.S. Prober C.G. Fischer M. Principles and practice of pediatric infectious diseases. Elsevier, Philadelphia, PA2018: 1169-1176
        • Nobel J.
        • Centers for Disease Control and Prevention (CDC)
        Measles rash desquamation.
        1968 (Available at:)
        • World Health Organization (WHO)
        Manual for the laboratory diagnosis of measles and rubella virus infections.
        2nd edn. WHO, Geneva, Switzerland2007 (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        The Pink Book; Measles; Epidemiology of vaccine preventable diseases.
        2019 (Available at:)
        • Beckford A.P.
        • Kaschula R.O.
        • Stephen C.
        Factors associated with fatal cases of measles. A retrospective autopsy study.
        S Afr Med J. 1985; 68: 858-863
        • Griffin D.E.
        Measles virus and the nervous system.
        in: Tselis A.C. Booss J. Neurovirology. Elsevier, Philadelphia2014: 577-590
        • Gohil S.K.
        • Okubo S.
        • Klish S.
        • Dickey L.
        • Huang S.
        • Zahn M.
        Healthcare workers and post-elimination era measles: lessons on acquisition and exposure prevention.
        Clin Infect Dis. 2016; 62: 166-172
        • World Health Organization (WHO)
        Measles vaccine: WHO position paper.
        Wkly Epidemiol Rec. 2009; 35: 349-360
        • World Health Organization (WHO)
        Treating measles in children.
        2004 (Available at:)
        • Bichon A.
        • Aubry C.
        • Benarous L.
        • et al.
        Case report: ribavirin and vitamin A in a severe case of measles.
        Medicine (Baltimore). 2017; 96: e9154
        • Pal G.
        Effects of ribavirin on measles.
        J Indian Med Assoc. 2011; 109: 666-667
        • American College of Emergency Physicians (ACEP)
        Immunization of adults and children in the emergency department.
        2015 (Available at:)
        • Steenhuysen J.
        U.S. doctors use medical records to fight measles outbreak.
        2019 (Available at:)